:M09AB02 Collagenase clostridium histolyticum
In February 2011, the European Commission's Committee for Medicinal Products for Human Use approved the product for the treatment of Dupuytren's contracture in adults with a palpable cord by 'properly trained' doctors.
Collagenase clostridium histolyticum (marketed as Xiaflex by Auxilium), a drug originally approved by the FDA to treat Dupuytren's contracture, is now an FDA approved injectable drug for treatment of Peyronie's disease.
Clostridium botulinum | Clostridium difficile | Collagenase clostridium histolyticum | Clostridium tetani | Clostridium perfringens | Clostridium | Collagenase ''clostridium histolyticum'' | Clostridium phytofermentans | Clostridium fallax | Clostridium acetobutylicum |